Circulating tumor DNA based MRD detection
We measure circulating tumor DNA (ctDNA) as a liquid biopsy biomarker for molecular residual disease (MRD) and correlate with cancer survival.
Department of Radiation Oncology
We measure circulating tumor DNA (ctDNA) as a liquid biopsy biomarker for molecular residual disease (MRD) and correlate with cancer survival.